Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Renal Cell

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

NGR-TNF in Treating Patients With Advanced Solid Tumors

NCT00098943

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +60 more
Locations: University Medical Center Hamburg - Eppendorf Hamburg, Germany

Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands

View Trial Details

Completed

Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer

NCT00033904

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Anchorage, Alaska, United States

Tucson, Arizona, United States

Los Angeles, California, United States

San Francisco, California, United States

View all 76 locations

View Trial Details

Completed

Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer

NCT00338884

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Pfizer Investigational Site Córdoba, Córdoba Province, Argentina

Pfizer Investigational Site Rosario, Santa Fe Province, Argentina

Pfizer Investigational Site Buenos Aires, Argentina

Pfizer Investigational Site Adelaide, South Australia, Australia

View all 15 locations

View Trial Details

Completed

Non-Interventional Study (NIS) In Patients With Advanced And/Or Metastatic Renal Cell Carcinoma (mRCC) Treated With SUTENT®

NCT00684645

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Pfizer Investigational Site Brno, Czechia

Pfizer Investigational Site Brno, Czechia

Pfizer Investigational Site Brno, Czechia

Pfizer Investigational Site Chomutov, Czechia

View all 20 locations

View Trial Details

Completed

BMS 247550 to Treat Kidney Cancer

NCT00030992

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

NCT01158534

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer

NCT00282048

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Pfizer Investigational Site Chicago, Illinois, United States

Pfizer Investigational Site The Bronx, New York, United States

Pfizer Investigational Site Cleveland, Ohio, United States

Pfizer Investigational Site Philadelphia, Pennsylvania, United States

View Trial Details

Completed

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

NCT00088374

Conditions: Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +26 more
Locations: National Cancer Institute, National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Completed

Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer

NCT00002737

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Onze Lieve Vrouw Ziekenhuis Aalst Aalst, Belgium

Algemeen Ziekenhuis Middelheim Antwerp, Belgium

Institut Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

View all 27 locations

View Trial Details

Completed

IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease

NCT00523159

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Medizinische Universität Salzburg - Universitätsklinik für Innere Medizin III Salzburg, Austria

National Oncology Hospital - Urology Sofia, Bulgaria

Regional Oncodispensary with inpatient sector-Sofia District Sofia, Bulgaria

Charité Campus Mitte-Klinik für Urologie Berlin, Germany

View all 44 locations

View Trial Details